tirzepatide cause kidney stones (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Changes in 24-Hour Urine Chemistry

Ramirez E, Bellon T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castaner JL, Cabanas R, Fiandor A, Gonzalez-Ramos J, Herranz P, Cachafeiro L, Gonzalez-Herrada C, Gonzalez O, Aramburu JA, Laosa O, Hernandez R, Carcas AJ, Frias J (2017) Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population

Can weight loss help with conditions like high blood pressure or diabetes

On average, participants endorsed moderate AUD severity (Table)

Key Takeaways What researchers say now about cancer risks linked to GLP-1 Why are there concerns about thyroid cancer with these drugs How studies compare different GLP-1 options like semaglutide Which patients might face higher risks and need extra monitoring Why talking to a doctor is critical before starting therapy What Are GLP-1 Medications

Understanding the best practices for injection can improve comfort, reduce side effects, and enhance treatment outcomes

Support Healthy Blood Sugar Levels*